Our Resources | Association for Accessible Medicines

AAM All Access Podcast - Dan Leonard interviews pharmaceutical industry veteran Bob Billings

Dr. Robert Califf

Nov 12, 2021 | Rachel Schwartz

AAM Statement on the Nomination of Dr. Robert Califf to Lead FDA

HHS Proposal Will Help America’s Patients Realize the Full Value of Their Generics and Biosimilars

Nov 12, 2021 | Monét Stanford

Medicare Negotiations Serve as a Catalyst to a Perpetual Monopoly

Nov 10, 2021 | Rachel Schwartz

Paula Witt Joins AAM as Senior Manager, State Government Affairs

Misguided Drug Pricing Reform

Nov 2, 2021 | Rachel Schwartz

AAM Opposes Latest Prescription Drug Reform Framework

Cover of A Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain

Nov 2, 2021 | Jonathan Kimball

Second Edition of AAM’s Blueprint to Enhance the Security of the U.S. Pharmaceutical Supply Chain

Second Annual Global Biosimilars Week #GlobalBiosimilarsWeek

Oct 31, 2021 | Rachel Schwartz

Biosimilars Council Encourages Stakeholders, Advocates to Join #GlobalBiosimilarsWeek

AAM All Access Podcast

Oct 27, 2021 | Dan Leonard

AAM All Access Podcast: Celebrating Pharmacists

Bureau of Legislative Affairs

Oct 27, 2021 | Rachel Schwartz

Kenneth Westberry Joins AAM As Senior Manager, State Government Affairs

CPI - Medicaid Generics Tax

Oct 26, 2021 | Erik Komendant

Inflation-Based Rebates Need Not Apply

AAM Amicus Brief

Oct 22, 2021 | Rachel Schwartz

GLAXOSMITHKLINE LLC and SMITHKLINE BEECHAM (CORK) LIMITED v. TEVA PHARMACEUTICALS USA, INC.

AAM All Access Podcast

Oct 18, 2021 | Dan Leonard

AAM All Access Podcast: Lupin’s Vinita Gupta

Group of multi-ethnic women holding breast cancer awareness ribbons in their hands and wearing pink shirts

Oct 18, 2021 | Rachel Schwartz

Five Breast Cancer Facts